RS51305B - Derivati 1,2,4,5-tetrahidro-3h-benzazepina, postupak za njihovu izradu i farmaceutske smeše koje ih sadrže - Google Patents

Derivati 1,2,4,5-tetrahidro-3h-benzazepina, postupak za njihovu izradu i farmaceutske smeše koje ih sadrže

Info

Publication number
RS51305B
RS51305B RSP-2010/0245A RSP20100245A RS51305B RS 51305 B RS51305 B RS 51305B RS P20100245 A RSP20100245 A RS P20100245A RS 51305 B RS51305 B RS 51305B
Authority
RS
Serbia
Prior art keywords
group
branched
linear
represent
same
Prior art date
Application number
RSP-2010/0245A
Other languages
English (en)
Inventor
Jean-Louis Peglion
Bertrand Goument
Aimée Dessinges
Pascal Caignard
Jean-Paul Vilaine
Catherine Thollon
Nicole Villeneuve
Stefano Chimenti
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39323822&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS51305(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of RS51305B publication Critical patent/RS51305B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B55/00—Racemisation; Complete or partial inversion
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
RSP-2010/0245A 2007-09-11 2008-09-11 Derivati 1,2,4,5-tetrahidro-3h-benzazepina, postupak za njihovu izradu i farmaceutske smeše koje ih sadrže RS51305B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0706346A FR2920773B1 (fr) 2007-09-11 2007-09-11 Derives de 1,2,4,5-tetrahydro-3h-benzazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
RS51305B true RS51305B (sr) 2010-12-31

Family

ID=39323822

Family Applications (1)

Application Number Title Priority Date Filing Date
RSP-2010/0245A RS51305B (sr) 2007-09-11 2008-09-11 Derivati 1,2,4,5-tetrahidro-3h-benzazepina, postupak za njihovu izradu i farmaceutske smeše koje ih sadrže

Country Status (45)

Country Link
US (1) US8076325B2 (sr)
EP (1) EP2036892B1 (sr)
JP (1) JP4932805B2 (sr)
KR (1) KR101078076B1 (sr)
CN (1) CN101386594B (sr)
AP (1) AP2384A (sr)
AR (1) AR068386A1 (sr)
AT (1) ATE460401T1 (sr)
AU (1) AU2008207585B2 (sr)
BR (1) BRPI0804091B8 (sr)
CA (1) CA2639349C (sr)
CL (1) CL2008002654A1 (sr)
CO (1) CO6020016A1 (sr)
CR (1) CR10229A (sr)
CU (1) CU23706B7 (sr)
CY (1) CY1110034T1 (sr)
DE (1) DE602008000786D1 (sr)
DK (1) DK2036892T3 (sr)
EA (1) EA014756B1 (sr)
EC (1) ECSP088731A (sr)
ES (1) ES2342511T3 (sr)
FR (1) FR2920773B1 (sr)
HK (1) HK1129667A1 (sr)
HN (1) HN2008001393A (sr)
HR (1) HRP20100259T1 (sr)
JO (1) JO2652B1 (sr)
MA (1) MA30315B1 (sr)
ME (1) ME00981B (sr)
MX (1) MX2008011164A (sr)
MY (1) MY143079A (sr)
NI (1) NI200800247A (sr)
NZ (1) NZ571143A (sr)
PA (1) PA8795301A1 (sr)
PE (1) PE20090620A1 (sr)
PL (1) PL2036892T3 (sr)
PT (1) PT2036892E (sr)
RS (1) RS51305B (sr)
SA (1) SA08290567B1 (sr)
SG (1) SG151172A1 (sr)
SI (1) SI2036892T1 (sr)
TW (1) TWI374029B (sr)
UA (1) UA100003C2 (sr)
UY (1) UY31305A1 (sr)
WO (1) WO2009066041A2 (sr)
ZA (1) ZA200807586B (sr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2961105B1 (fr) * 2010-06-15 2013-02-08 Servier Lab Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
FR2984319B1 (fr) * 2011-12-20 2013-12-27 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2984320B1 (fr) * 2011-12-20 2013-11-29 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2988720B1 (fr) * 2012-03-27 2014-03-14 Servier Lab Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
TWI654180B (zh) 2012-06-29 2019-03-21 美商艾佛艾姆希公司 殺真菌之雜環羧醯胺
FR3003859B1 (fr) * 2013-03-26 2015-03-13 Servier Lab "procede de synthese de derives de la 7,8-dimethoxy-1,3-dihydro-2h-3-benzazepin-2-one et application a la synthese de l'ivabradine"
US9333208B2 (en) 2013-07-16 2016-05-10 Movses H. Karakossian HCN inhibitors affecting ganglion cell function and visual function
FR3020810B1 (fr) * 2014-05-06 2016-05-06 Servier Lab Nouveau sel de l'ivabradine et son procede de preparation.
FR3046793B1 (fr) * 2016-01-14 2018-01-05 Les Laboratoires Servier Nouveaux derives de phosphinanes et azaphosphinanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP3615052B1 (en) * 2017-04-27 2023-01-25 The University of Hong Kong Use of hcn inhibitors for treatment of cancer
CN112724001B (zh) * 2019-10-28 2022-12-13 鲁南制药集团股份有限公司 一种伊伐布雷定手性中间体化合物
CN113372273B (zh) * 2020-03-10 2023-05-09 鲁南制药集团股份有限公司 一种伊伐布雷定中间体化合物iv
CN113372274B (zh) * 2020-03-10 2023-03-24 鲁南制药集团股份有限公司 一种伊伐布雷定的制备方法
JP7315806B1 (ja) 2021-08-31 2023-07-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 単環ピリジン誘導体の製造方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3119874A1 (de) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
DE3418270A1 (de) 1984-05-17 1985-11-21 Dr. Karl Thomae Gmbh, 7950 Biberach Neue aminotetralinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
GB8707120D0 (en) * 1987-03-25 1987-04-29 Pfizer Ltd Antiarrhythmic agents
JPH02193971A (ja) * 1989-01-20 1990-07-31 Yamanouchi Pharmaceut Co Ltd トリ置換―２，３，４，５―テトラヒドロベンズアゼピン誘導体とその中間体
FR2681862B1 (fr) * 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
EP0700389A1 (en) * 1993-05-27 1996-03-13 Smithkline Beecham Laboratoires Pharmaceutiques Anti-arrhythmic n-substituted 3-benzazepines or isoquinolines
TW527355B (en) * 1997-07-02 2003-04-11 Bristol Myers Squibb Co Inhibitors of farnesyl protein transferase
US6514964B1 (en) * 1999-09-27 2003-02-04 Amgen Inc. Fused cycloheptane and fused azacycloheptane compounds and their methods of use
FR2882554B1 (fr) * 2005-02-28 2007-05-04 Servier Lab Forme critalline beta d du chlorhydrate de l'ivabradine, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2894826B1 (fr) 2005-12-21 2010-10-22 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur calcique et les compositions pharmaceutiques qui la contiennent

Also Published As

Publication number Publication date
PL2036892T3 (pl) 2010-08-31
ES2342511T3 (es) 2010-07-07
BRPI0804091B1 (pt) 2020-09-29
CN101386594B (zh) 2012-05-16
CO6020016A1 (es) 2009-03-31
ATE460401T1 (de) 2010-03-15
US20090069296A1 (en) 2009-03-12
PA8795301A1 (es) 2009-04-23
CY1110034T1 (el) 2015-01-14
JO2652B1 (en) 2012-06-17
AR068386A1 (es) 2009-11-11
SA08290567B1 (ar) 2011-06-22
CL2008002654A1 (es) 2009-03-20
US8076325B2 (en) 2011-12-13
WO2009066041A2 (fr) 2009-05-28
EP2036892A1 (fr) 2009-03-18
CU23706B7 (es) 2011-10-05
JP4932805B2 (ja) 2012-05-16
WO2009066041A3 (fr) 2009-12-17
FR2920773A1 (fr) 2009-03-13
ECSP088731A (es) 2008-10-31
BRPI0804091B8 (pt) 2021-05-25
MX2008011164A (es) 2009-03-10
UA100003C2 (ru) 2012-11-12
MA30315B1 (fr) 2009-04-01
DE602008000786D1 (de) 2010-04-22
AU2008207585B2 (en) 2013-08-22
CN101386594A (zh) 2009-03-18
MY143079A (en) 2011-02-28
EA014756B1 (ru) 2011-02-28
CR10229A (es) 2008-11-26
ZA200807586B (en) 2011-04-28
CA2639349A1 (fr) 2009-03-11
CU20080165A7 (es) 2011-03-21
CA2639349C (fr) 2011-03-22
EP2036892B1 (fr) 2010-03-10
EA200801828A2 (ru) 2009-04-28
BRPI0804091A2 (pt) 2009-05-05
TWI374029B (en) 2012-10-11
KR101078076B1 (ko) 2011-10-28
PE20090620A1 (es) 2009-05-30
DK2036892T3 (da) 2010-06-07
NI200800247A (es) 2011-01-10
NZ571143A (en) 2010-04-30
KR20090027164A (ko) 2009-03-16
HRP20100259T1 (hr) 2010-06-30
AP2008004589A0 (en) 2008-08-31
SI2036892T1 (sl) 2010-06-30
HN2008001393A (es) 2011-05-11
FR2920773B1 (fr) 2009-10-23
EA200801828A3 (ru) 2009-08-28
HK1129667A1 (sr) 2009-12-04
ME00981B (me) 2012-06-20
UY31305A1 (es) 2008-10-31
PT2036892E (pt) 2010-05-10
AU2008207585A1 (en) 2009-03-26
JP2009108032A (ja) 2009-05-21
TW200918076A (en) 2009-05-01
AP2384A (en) 2012-03-21
SG151172A1 (en) 2009-04-30

Similar Documents

Publication Publication Date Title
RS51305B (sr) Derivati 1,2,4,5-tetrahidro-3h-benzazepina, postupak za njihovu izradu i farmaceutske smeše koje ih sadrže
HRP20201433T1 (hr) Supstituirani (e)-n´- (1-feniletiliden) analozi benzohidrazida kao inhibitori histonske demetilaze
RS50755B (sr) Supstituisani aril i heteroaril derivati kao modulatori metabolizma i profilakse i lečenje poremećaja proisteklih iz toga
AR068057A1 (es) Esteres de 1-fenil-2-(3,5-dicloro)-piridina, metodo de preparacion de los mismos, composiciones farmaceuticas que los contienen y usos de los mismos para el tratamiento de enfermedades del tracto respiratorio.
RS54270B1 (sr) Derivati pirolotriazinona kao pi3k inhibitori
HRP20090334T1 (en) 3-[4-heterocyclyl-1,2,3-triazol-1-yl]-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases
RS52210B (sr) Ciklopenta [d] pirimidini kao inhibitori akt proteinskih kinaza
RU2018121834A (ru) Новое соединение бифенила или его соль
RS52061B (sr) Derivati pirazolil-aminopiridina korisni kao inhibitori kinaze
RU2012108629A (ru) Фенилэтинильные производные в качестве ингибиторов вируса гепатита с
RS54708B1 (sr) Ariletinil derivati
AR081426A1 (es) Derivados de pirazol inhibidores del receptor sigma
AR070539A1 (es) Inhibidores de la actividad de proteina tirosina quinasa
AR049487A1 (es) Compuestos de imidazol sustituidos
AR049276A1 (es) Compuestos carboxamidos opiodes y composiciones farmaceuticas que los contienen
AR044715A1 (es) Compuestos tipo amidas que inhiben la reabsorcion de las monoaminas
WO2011021726A3 (en) Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
MY169179A (en) Novel piperidine compound or salt thereof
AR085088A1 (es) Inhibidores de histona desacetilasa y composiciones farmaceuticas que los contienen
HRP20090581T1 (hr) Spojevi i postupci za liječenje dislipidemije
AR071512A1 (es) Derivados de imidazolidinona como inhibidores de 11b-hsd1
HRP20110785T8 (en) Pyrimidinyl-piperazines useful as dopamine d3/d2 receptor ligands
RS50527B (sr) Derivati indanil-piperazina, proces njihove izrade i farmaceutske smeše koje ih sadrže
MY165634A (en) Pyrazole compounds having therapeutic effect on multiple myeloma
AR056418A1 (es) Derivados de bencimidazol como 5-ht6, 5-ht2a, metodo para la obtencion del compuesto y el uso para la fabricacion de un mediicamento